Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  imiquimod
Find trials that include:  Any drugs shown
Results 1-9 of 9 for your search:
Start Over
Imiquimod, Fluorouracil, or Observation in Treating Patients With High-Grade Anal Squamous Skin Lesions Who Are HIV-Positive
Phase: Phase III
Type: Treatment
Age: 27 and over
Trial IDs: AMC-088, NCI-2013-02288, NCT02059499
Topical or Ablative Treatment in Preventing Anal Cancer in Patients with HIV and Anal High-Grade Squamous Intraepithelial Lesions
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Age: 35 and over
Trial IDs: AMC-A01, NCI-2014-00636, NCT02135419
Imiquimod, Cyclophosphamide, and Radiation Therapy in Treating Patients with Breast Cancer with Skin Metastases
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NYU 11-00598, NCI-2011-02879, NCT01421017
Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: STML-701-0114, NCI-2014-01008, NCT02078648
Basiliximab in Treating Patients with Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Phase: Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: Pro00000581, NCI-2011-03848, CDR0000579683, SPORE Project 3, DUMC-PRO00000581, NCT00626483
Vaccine Therapy with or without Imiquimod in Treating Patients with High-Grade Cervical Intraepithelial Neoplasia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Prevention
Age: 18 and over
Trial IDs: J0656, NCI-2011-00532, CDR0000617261, CIR00001225, JHOC-J0656, NA_00002176, NCT00788164
Imiquimod and Vaccine Therapy in Treating Younger Patients with Recurrent or Progressive Glioblastoma Multiforme or Diffuse Intrinsic Pontine Glioma
Phase: No phase specified
Type: Treatment
Age: 3 and over
Trial IDs: 2009LS136, NCI-2012-00322, NCT01400672
Vaccine Therapy and Imiquimod in Treating Patients With High Risk or Recurrent Grade II Gliomas
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 11-136, NCI-2013-00078, NCT01678352
Start Over